Roselabs Finance Complete Financial Statements
In FYNone, Roselabs Finance (ROSELABS) reported revenue ₹1 Cr, net profit ₹0 Cr and EPS ₹-0.30. Full financial statements from FY2011 to FY2025 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Roselabs Finance share price today.
12 Years of Data
2025 - 2011
Complete Financial Data Export
Profitability Ratios
Operating Margin
-44.00%
2025 data
Balance Sheet Ratios
ROSELABS Revenue, Net Profit & EBITDA — Year-on-Year Growth
ROSELABS YoY (March 2025 vs Period).
Assets Growth
-100.0%
Year-over-Year
Equity Growth
-25.0%
Year-over-Year
Liabilities Growth
-100.0%
Year-over-Year
ROSELABS Income Statement — Revenue, EBITDA & Net Profit
Roselabs Finance revenue ₹1 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹-0.30 (None). Explore Roselabs Finance intrinsic worth to estimate fundamental worth using multiple valuation models.
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 | March 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 4 | 2 | 8 | 14 | 0 |
| Expenses | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 3 | 2 | 8 | 10 | 0 |
| EBITDA | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 4 | 0 |
| Operating Profit Margin % | -1.00% | -44.00% | -15.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 7.00% | 21.00% | 4.00% | 29.00% | 0.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 3 | 4 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 2 | 0 | -3 | 0 | 0 | -1 | -1 | -2 | 1 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 2 | 0 | -3 | 0 | 0 | 0 | -1 | -2 | 1 | 0 |
| Earnings Per Share (₹) | -0.30 | -0.29 | -0.13 | 2.02 | -0.44 | -2.57 | -0.14 | -0.39 | -0.43 | -1.43 | -2.40 | 0.49 | 0.05 |
ROSELABS Balance Sheet — Assets, Liabilities & Shareholders' Equity
ROSELABS total assets ₹0 Cr, total equity ₹-5 Cr, total liabilities ₹0 Cr (2025).
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Total Assets | 0 | 2 | 0 | 0 | 0 | 1 | 1 | 7 | 29 | 23 | 31 | 42 |
| Current Assets | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 3 | 17 | 18 | 22 | 40 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 2 | 0 | 0 | 0 | 1 | 1 | 7 | 29 | 23 | 31 | 42 |
| LIABILITIES | ||||||||||||
| Total Liabilities | 0 | 2 | 0 | 0 | 0 | 1 | 1 | 7 | 29 | 23 | 31 | 42 |
| Current Liabilities | 5 | 5 | 4 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | ||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||
| Total Equity | -5 | -4 | -4 | -6 | -6 | -3 | -3 | -3 | -3 | -1 | 1 | 8 |
| Share Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves & Surplus | -15 | -14 | -14 | -16 | -16 | -13 | -13 | -13 | -13 | -11 | -9 | -2 |
ROSELABS Cash Flow Statement — Operating, Investing & Financing
Roselabs Finance operating cash flow ₹0 Cr, investing ₹0 Cr, financing ₹0 Cr, net cash flow ₹0 Cr (2025).
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | 0 | 1 | 0 | 0 | 0 | -1 | 23 | -6 | 7 | -2 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | 0 | 0 | -1 | 0 | 0 | 0 | 0 | -24 | 6 | -7 | 2 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 |